FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897429402> ?p ?o ?g. }

• W2897429402 abstract "Graft-versus-host disease (GvHD), a severe complication of allogeneic hematopoietic stem cell transplantation, significantly affects the post-transplant morbidity and mortality. Systemic steroids remain the gold standard for the initial management of GvHD. However, up to 60% of patients will not sufficiently respond to steroids. Extracorporeal photopheresis (ECP), a cell-based immunotherapy, has shown good clinical results in such steroid-refractory/resistant GvHD patients. Given its immunomodulatory, but not global immunosuppressive and steroid-sparing capacity, ECP constitutes an attractive option. In the case of GvHD, the balance of immune cells is destroyed: effector cells are not any longer efficiently controlled by regulatory cells. ECP therapy may restore this balance. However, the precise mechanism and the impact of ECP on anti-viral/anti-leukemic function remain unclear. In this study, 839 ECP treatments were performed on patients with acute GvHD (aGvHD) and chronic GvHD (cGvHD). A comprehensive analysis of effector and regulatory cells in patients under ECP therapy included multi-parametric flow cytometry and tetramer staining, LuminexTM-based cytokine, interferon-γ enzyme-linked immunospot and chromium-51 release assays. Gene profiling of myeloid-derived suppressor cells (MDSCs) was performed by microarray analysis. Immunologically, modulations of effector and regulatory cells as well as proinflammatory cytokines were observed under ECP treatment: (1) GvHD-relevant cell subsets like CD62L+ NK cells and newly defined CD19hiCD20hi B cells were modulated, but (2) quantity and quality of anti-viral/anti-leukemic effector cells were preserved. (3) The development of MDSCs was promoted and switched from an inactivated subset (CD33-CD11b+) to an activated subset (CD33+CD11b+). (4) The frequency of Foxp3+CD4+ regulatory T cells (Tregs) and CD24+CD38hi regulatory B cells was considerably increased in aGvHD patients, and Foxp3+CD8+ Tregs in cGvHD patients. (5) Proinflammatory cytokines like IL-1β, IL-6, IL-8 and TNF-α were significantly reduced. In summary, ECP constitutes an effective immunomodulatory therapy for patients with steroid-refractory/resistant GvHD without impairment of anti-viral/leukemia effects." @default.
• W2897429402 created "2018-10-26" @default.
• W2897429402 creator A5000363220 @default.
• W2897429402 creator A5002643568 @default.
• W2897429402 creator A5003395773 @default.
• W2897429402 creator A5017514499 @default.
• W2897429402 creator A5025115907 @default.
• W2897429402 creator A5028388949 @default.
• W2897429402 creator A5031568690 @default.
• W2897429402 creator A5044008964 @default.
• W2897429402 creator A5050767715 @default.
• W2897429402 creator A5058925624 @default.
• W2897429402 creator A5059935166 @default.
• W2897429402 creator A5067574718 @default.
• W2897429402 creator A5069516336 @default.
• W2897429402 creator A5072680083 @default.
• W2897429402 creator A5074376310 @default.
• W2897429402 creator A5077605804 @default.
• W2897429402 creator A5077620734 @default.
• W2897429402 creator A5078894628 @default.
• W2897429402 creator A5081737366 @default.
• W2897429402 creator A5082851070 @default.
• W2897429402 creator A5085146093 @default.
• W2897429402 creator A5088686166 @default.
• W2897429402 creator A5090815387 @default.
• W2897429402 date "2018-10-08" @default.
• W2897429402 modified "2023-10-12" @default.
• W2897429402 title "Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects" @default.
• W2897429402 cites W1510827637 @default.
• W2897429402 cites W1562818110 @default.
• W2897429402 cites W1676794103 @default.
• W2897429402 cites W1918510565 @default.
• W2897429402 cites W1926253509 @default.
• W2897429402 cites W1963701987 @default.
• W2897429402 cites W1965174970 @default.
• W2897429402 cites W1970490705 @default.
• W2897429402 cites W1971059638 @default.
• W2897429402 cites W1975626385 @default.
• W2897429402 cites W1981428999 @default.
• W2897429402 cites W1986608520 @default.
• W2897429402 cites W1988942618 @default.
• W2897429402 cites W1991757009 @default.
• W2897429402 cites W1994892164 @default.
• W2897429402 cites W2000487018 @default.
• W2897429402 cites W2005159588 @default.
• W2897429402 cites W2010221217 @default.
• W2897429402 cites W2012030256 @default.
• W2897429402 cites W2012434943 @default.
• W2897429402 cites W2015672274 @default.
• W2897429402 cites W2017467835 @default.
• W2897429402 cites W2021827061 @default.
• W2897429402 cites W2023459448 @default.
• W2897429402 cites W2027063158 @default.
• W2897429402 cites W2028525361 @default.
• W2897429402 cites W2031426920 @default.
• W2897429402 cites W2039174045 @default.
• W2897429402 cites W2040790884 @default.
• W2897429402 cites W2042055313 @default.
• W2897429402 cites W2062069799 @default.
• W2897429402 cites W2063984711 @default.
• W2897429402 cites W2065573353 @default.
• W2897429402 cites W2066885693 @default.
• W2897429402 cites W2069382319 @default.
• W2897429402 cites W2081806329 @default.
• W2897429402 cites W2085828818 @default.
• W2897429402 cites W2086092185 @default.
• W2897429402 cites W2088127225 @default.
• W2897429402 cites W2088328410 @default.
• W2897429402 cites W2092408112 @default.
• W2897429402 cites W2108265306 @default.
• W2897429402 cites W2116012250 @default.
• W2897429402 cites W2117232564 @default.
• W2897429402 cites W2117786049 @default.
• W2897429402 cites W2127331235 @default.
• W2897429402 cites W2146949490 @default.
• W2897429402 cites W2149055573 @default.
• W2897429402 cites W2160875559 @default.
• W2897429402 cites W2165859652 @default.
• W2897429402 cites W2170334907 @default.
• W2897429402 cites W2206276344 @default.
• W2897429402 cites W2213572759 @default.
• W2897429402 cites W2264817694 @default.
• W2897429402 cites W2321365245 @default.
• W2897429402 cites W2337899296 @default.
• W2897429402 cites W2379365975 @default.
• W2897429402 cites W2512195020 @default.
• W2897429402 cites W2557740095 @default.
• W2897429402 cites W2586652839 @default.
• W2897429402 cites W2610187571 @default.
• W2897429402 cites W2612502272 @default.
• W2897429402 cites W2622829023 @default.
• W2897429402 cites W2775899459 @default.
• W2897429402 cites W2786133182 @default.
• W2897429402 cites W2792034539 @default.
• W2897429402 cites W2793958408 @default.
• W2897429402 cites W4244712895 @default.
• W2897429402 doi "https://doi.org/10.3389/fimmu.2018.02207" @default.
• W2897429402 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6186805" @default.
• W2897429402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30349527" @default.
• W2897429402 hasPublicationYear "2018" @default.

• next